Acne Drugs Market Depth Analysis and Industry Forecast 2020 To 2027 | Almirall SA, Pfizer Inc., Mylan NV, GSK

The increase in the prevalence of acne is a major factor contributing to the growth of the acne medication market.

PORTLAND, OREGON, USA, July 13, 2022 / — Acne medications are medications indicated for the treatment of acne. This includes many prescription and over-the-counter medications such as retinoids, isotretinoin, antibiotics, salicylic acid, benzoyl peroxide, and oral contraceptives. Acne is one of the most common skin conditions caused by changes in the structure of the skin. It affects millions of adolescents around the world. It is characterized by pimples, blackheads, oily skin and blemishes.

Explore more information @

The report offers an in-depth analysis of major investment pockets, market trends, and key market players that can help new market entrants develop lucrative strategies and make informed decisions. The report offers a study of key impacting factors and competitive intelligence based on the top 10 investment pockets influencing market growth.

According to a new report published by Allied Market Research, “Acne Medicine Market: Opportunity Analysis and Industry Forecast, 2019-2027”, the global acne medication market is valued at $11,865.9 million in 2019 and is expected to reach $13,357.57 million by 2027 at a CAGR of 3.80% from 2020 to 2027.
Asia Pacific is expected to register the highest CAGR during the forecast period, driven by an increase in product launches, increased demand for acne treatments and rising cost of care health, as well as an increased awareness of newly developed treatments that can replace traditional acne.

There are two types of acne, non-inflammatory and inflammatory, where the latter takes longer to heal and can have a permanent effect on the skin. It usually affects the skin with more sweat glands than the upper chest, back and face. The side effects associated with the use of acne medications and the presence of alternative treatments are hampering the growth of the market. On the other hand, the development of effective drugs with low side effects and high market potential in unused emerging economies is expected to provide profitable growth opportunities for market growth. The increase in the prevalence of acne is a major factor contributing to the growth of the acne medication market. Additionally, other factors driving the market include unhealthy urban lifestyles and the presence of potent acne drugs in the pipeline.

Speak with Analyst @

The global acne medication market is segmented into therapeutic class, formulation, type, acne type, distribution channel, and region. By therapeutic class, the market is divided into retinoids, antibiotics, salicylic acid, benzoyl peroxide and others. The retinoid segment is further classified into topical retinoid and combination retinoid and oral retinoid (isotretinoin). Moreover, the Antibiotics segment is further sub-segmented into Topical Antibiotics and Combination Antibiotics and Oral Antibiotics. Based on formulation, the market is divided into topical medications and oral medications. By type, it is divided into prescription drugs and over-the-counter (OTC) drugs. By type of acne, it is fragmented into non-inflammatory and inflammatory acne. By distribution channel, it is classified into retail store, pharmacy and parapharmacy and e-commerce. Regionally, it is analyzed across North America, Europe, Asia-Pacific and LAMEA.

Main market players
• Almirall Sa
• Bausch Health Companies Inc.
• Glaxosmithkline Plc (Gsk)
• Johnson & Johnson
• Galderma SA
• Mayne Pharma Group Limited
• Mylan SA
• Sun Pharmaceutical Industries Limited
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.

Main advantages:
• Quantitative analysis of current Acne Drugs market trends and future estimates from 2020 to 2027, which helps to identify current opportunities in the Acne Drugs market.
• An in-depth analysis of the different regions is likely to provide a detailed understanding of current trends for stakeholders to formulate region-specific plans.
• A comprehensive analysis of factors driving and restraining the Acne Drugs Market growth is provided.
• Major regulatory guidelines for Acne Drugs market are critically covered as per region.
• In-depth analysis of various regions provides information that would enable companies to strategically plan their trade movements.

Customization Request @

Related report:
3D Cell Culture Market
Molecular diagnostics market

We also offer regional and national reports:
• North America acne medication market
• Japanese acne medicine market
• South Korean acne medicine market
• Acne medication market in Singapore
• Australian acne medication market
• European acne medicine market

About Us:

Allied Market Research (AMR) is a full-service market research and business consulting division of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unparalleled quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.

AMR introduces its premium subscription-based online library Avenue, designed specifically to provide a unique and cost-effective solution for businesses, investors and universities. With Avenue, subscribers can benefit from a comprehensive repository of reports on over 2,000 niche industries and over 12,000 company profiles. Additionally, users can get online access to quantitative and qualitative data in PDF and Excel formats, as well as analyst support, customization, and updated versions of reports.

David Correa
Allied Analytics LLP
write to us here
Visit us on social media: